Cargando…
A small compound spindlactone A sensitizes human endometrial cancer cells to TRAIL-induced apoptosis via the inhibition of NAD(P)H dehydrogenase quinone 1 [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292400/ https://www.ncbi.nlm.nih.gov/pubmed/30573981 http://dx.doi.org/10.2147/OTT.S196977 |
Ejemplares similares
-
A small compound spindlactone A sensitizes human endometrial cancer cells to
TRAIL-induced apoptosis via the inhibition of NAD(P)H dehydrogenase quinone
1
por: Zhao, Xiang-Zhai, et al.
Publicado: (2018) -
Riboflavin compounds show NAD(P)H dependent quinone oxidoreductase-like quinone reducing activity
por: Nagase, Midori, et al.
Publicado: (2023) -
Corrigendum: Interspecific comparison of sensitivity to paralytic compounds
Publicado: (2020) -
Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome
por: Atiomo, William, et al.
Publicado: (2017) -
Cancer Cell Sensitivity to Redox-Cycling Quinones is Influenced by NAD(P)H: Quinone Oxidoreductase 1 Polymorphism
por: Glorieux, Christophe, et al.
Publicado: (2019)